CME Group (CME) Stock Sees Fair Value Lift As Analysts Back Record Volumes

What happened: A model's fair value estimate for CME Group moved from US$292 to US$316, feeding into higher analyst price targets tied to record Q3 volumes. Key numbers: Fair value US$292 to US$316. Price targets in the US$300 to US$360 range. Revenue growth assumption 5.65% to 6.08%. Net profit margin 58.16% to 58.75%. Future P/E 28.25x to 28.51x. Discount rate 7.93%. Why it matters: JPMorgan, Morgan Stanley and Wells Fargo raised targets into the low to mid US$300s, while BofA and Deutsche Bank cite valuation and reduced upside, underscoring debate over how much is already priced in. Market: +0.2% today ($294.04), +12.2% YTD, 0.6x vol — as of 21:46 UTC

A model's fair value estimate for CME Group moved from US$292 to US$316, feeding into higher analyst price targets tied to record Q3 volumes.

JPMorgan, Morgan Stanley and Wells Fargo raised targets into the low to mid US$300s, while BofA and Deutsche Bank cite valuation and reduced upside, underscoring debate over how much is already priced in. Market: +0.2% today ($294.04), +12.2% YTD, 0.6x vol — as of 21:46 UTC